Cauda equina syndrome is the most time-critical diagnosis in faecal incontinence — the sacral nerve roots (S2–S4) control both the external anal sphincter (EAS) and the external urethral sphincter, and compression by a prolapsed lumbar disc (most commonly L4/L5 or L5/S1) causes simultaneous faecal and urinary incontinence with perineal sensory loss. Delay risks permanent sphincter dysfunction, so assessment and MRI are emergencies. GPs must recognise that the classic "saddle anaesthesia" description (numbness in the area that would contact a bicycle saddle) is a late sign — earlier features include bilateral sciatica, urinary hesitancy, reduced urinary stream, and constipation. Any patient with low back pain and new bowel or bladder symptoms must have cauda equina excluded urgently. Faecal incontinence is one of the most under-reported and under-treated conditions in primary care — it is common, particularly in care home residents. The majority of sufferers never discuss it with their GP due to shame, embarrassment, and the misconception that "nothing can be done." NICE CG49 (Faecal Incontinence, 2007) emphasises that GPs should proactively ask about FI in high-risk populations (multiparous women, elderly, IBD patients, post-pelvic radiotherapy patients, diabetics) rather than waiting for patients to volunteer the symptom.

The passive/urge distinction can suggest — but not prove — the mechanism, and FI is commonly multifactorial: passive FI (IAS dysfunction) responds to bulking agents (to increase stool consistency and reduce liquid leakage), rectal irrigation, and in severe cases sphincter augmentation (sacral nerve stimulation or injectable bulking agents around the IAS). Urge FI (EAS weakness or rectal hypersensitivity) responds to pelvic floor exercises, biofeedback, antidiarrhoeal agents (loperamide), and in severe cases sphincter repair or sacral nerve stimulation. Many patients have mixed passive and urge FI, particularly after obstetric sphincter injury where both the IAS and EAS are damaged. The Bristol Stool Scale is the universal stool consistency tool used in the UK — Types 1–2 (hard lumps/sausage) = constipation risk; Types 3–4 (normal formed) = target; Types 5–7 (loose/liquid) = diarrhoea risk/FI trigger. Aim for a stool consistency that is predictable and manageable for the individual; Bristol types 3–4 are often useful targets but are not mandatory. Overflow incontinence is the single most important and most commonly missed diagnosis in FI in elderly patients — examine (including DRE where tolerated) any elderly or constipated patient with "diarrhoea and incontinence" to exclude faecal impaction. Treating apparent diarrhoea with loperamide in a patient who actually has faecal loading can worsen impaction and risk obstruction.

Obstetric anal sphincter injury (OASI) is an important risk factor for faecal incontinence, and the temporal gap between the injury and symptom onset is one reason it is missed — women who sustained a 3rd or 4th degree tear at age 25 may not develop symptomatic FI until their 40s or 50s as the ageing pelvic floor loses the remaining sphincter reserve. GPs should specifically ask about obstetric history and 3rd/4th degree tear documentation in any woman presenting with FI, regardless of how long ago the deliveries were. Many women were never told they sustained a significant sphincter injury. Metformin-induced loose stools can tip a marginal sphincter into FI; if metformin is contributing, a modified-release switch can be considered individually. The lateral internal sphincterotomy (LIS) for anal fissure carries a well-documented risk of passive FI — this is part of informed consent before LIS. Post-LIS patients presenting with FI should be referred to colorectal surgery for physiological assessment (anal manometry) and consideration of sphincter repair.

Anorectal physiology studies (anal manometry + endoanal ultrasound) are the specialist investigations that define sphincter anatomy and function — they are performed by colorectal physiologists in tertiary colorectal centres and are the prerequisite for surgical intervention (sphincter repair, sacral nerve stimulation). Anal manometry measures resting pressure (IAS function) and squeeze pressure (EAS function). Reduced resting pressure = IAS damage; reduced squeeze = EAS damage. Endoanal ultrasound (360° sonography of the anal canal) visualises the sphincter ring and identifies defects — an anterior defect in a multiparous woman strongly suggests unrepaired obstetric injury. Faecal calprotectin helps separate IBD from IBS in diarrhoea-predominant FI — interpret with the local pathway cut-offs. It avoids unnecessary colonoscopy in the many patients whose FI is driven by IBS-D rather than inflammatory bowel disease. Check TSH when thyroid disease is clinically suspected.

Sacral nerve stimulation (SNS — also called sacral neuromodulation) is the most effective interventional treatment for FI in patients with intact but dysfunctional sphincters — it works by modulating the sacral nerve roots (S3) with a permanent implanted electrode (similar to a cardiac pacemaker), improving sphincter tone, rectal sensation, and rectal compliance simultaneously. NICE HTG61 (Sacral nerve stimulation for faecal incontinence — this guidance migrated IPG99; the recommendations remain unchanged) supports SNS for FI with normal arrangements for consent, audit and clinical governance, performed in specialist units, and NICE CG49 (2007) places it after failed conservative management. It helps many selected patients. It is also effective for urge FI where the sphincter is structurally intact but functionally weak (e.g., pudendal neuropathy). Biofeedback from a specialist pelvic floor physiotherapist is a specialised intervention that NICE CG49 recommends when FI does not respond to initial management — delivered by specialists, with benefit depending on selection and training. The biofeedback session uses anorectal manometry probes that display real-time sphincter squeeze pressure on a screen, allowing the patient to learn to coordinate and strengthen their sphincter contraction. The lack of access to NHS specialist pelvic floor physiotherapy in many areas is a significant barrier — Refer early to the continence service when symptoms are severe or quality of life is badly affected, and when initial management fails.

Loperamide's dual mechanism is important to understand — it is both an antidiarrhoeal (reduces gut motility via opioid receptor agonism in the gut wall) and an anal sphincter tonic agent (directly increases IAS resting tone via opioid receptors in the sphincter). This sphincter-tonic effect is independent of its antidiarrhoeal effect and is the reason loperamide is effective even in patients with formed stools who have IAS weakness — it supplements the resting tone of a weakened sphincter. Start low and titrate — the goal is a predictable, manageable stool (often Type 3–4), not constipation. A useful patient instruction is "take 2 mg half an hour before activities or situations where you most fear incontinence" (before going out, before a social event), which provides targeted symptom relief. Retrograde colonic irrigation (Peristeen, Qufora) is significantly underused in primary care — it helps selected neurogenic FI (spinal cord injury, MS, spina bifida) and some non-neurogenic incomplete evacuation, through specialist services. It works by flushing the left colon and rectum with warm water through a rectal catheter, producing a predictable complete evacuation and leaving the rectum empty. Training is given by a specialist nurse. NHS provision varies — many continence nurse specialists offer this service.

If metformin is contributing to loose stools, a modified-release formulation may help. The mechanism is that metformin IR is absorbed rapidly in the proximal small bowel, leaving a high concentration of drug in the distal small bowel and colon where it causes osmotic diarrhoea; modified-release metformin is often better tolerated; individualise the decision. Microscopic colitis (lymphocytic and collagenous colitis) is an important and frequently missed cause of watery diarrhoea causing FI in middle-aged and older women — it is strongly associated with PPI use (especially lansoprazole), NSAIDs, SSRIs, and statins. Colonoscopy appears macroscopically normal — the diagnosis requires colonic biopsies. Diagnosis and budesonide treatment are via gastroenterology. GPs should suspect microscopic colitis in any middle-aged woman with watery diarrhoea, incontinence, and a recent medication change to a PPI or NSAID.

NICE CG49 supports a sitting or squatting position where possible; a footstool is a low-risk measure but not a proven treatment. The aim for FI is that more complete evacuation leaves minimal residual stool in the rectal ampulla, reducing post-defecation passive leakage (the "soiling after passing stool" that many patients with IAS weakness describe). Ispaghula is a useful option for FI with loose stools — as a soluble fibre it absorbs water in the colon, converting liquid stool to a formed consistency (Type 3–4). It works equally well whether the underlying problem is IBS-D, post-infective diarrhoea, or mild IAS weakness — it is inexpensive, safe, and available OTC. The key instruction is to take it with adequate fluid (at least 200 ml per sachet) to prevent it from causing a bolus of dry fibre — without adequate fluid, Fybogel can worsen constipation.

Persisting with conservative care alone rarely helps when it has plateaued — patients plateau with lifestyle measures and pharmacotherapy alone if they have structural sphincter defects, neuropathy, or rectal compliance issues that require physiological assessment. The role of the GP is to initiate conservative management, exclude red flags, and refer to the continence service when improvement is insufficient (earlier if severe). The single most important quality indicator for FI management in primary care is asking the question — NICE QS54 (quality standard: Faecal incontinence in adults, 2014) identifies the proactive inquiry about FI in high-risk populations (multiparous women, elderly, post-pelvic radiotherapy, IBD, diabetes, pelvic surgery) as a key indicator. FI is among the most undertreated conditions in primary care, and the treatment gap is predominantly due to non-disclosure (patients do not volunteer the symptom) and non-asking (GPs do not ask). Incorporating a brief screening question ("Do you ever have difficulty controlling your bowels or have accidental leakage?") into annual reviews for high-risk patients would identify the majority of undiagnosed FI and initiate appropriate management years earlier.